Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cytegen

Cytegen
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$1M LATEST DEAL AMOUNT
Description

Developer of discovery platform designed to increase the human healthspan by reversing age-related decline in the body. The company's therapies target age-related health decline and neurodegenerative diseases like MS and Parkinson's as well as some other rare diseases, enabling patients to improve cellular metabolism.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • 1225 Discovery Parkway
  • Wauwatosa, WI 53226
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cytegen’s full profile, request a free trial.

Cytegen Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 12-Apr-2018 $1M 00.000 Completed Startup
3. Accelerator/Incubator 00000 Completed Startup
2. Grant 01-Jan-2017 $211K $350K Completed Startup
1. Seed Round 01-Aug-2015 $350K $350K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cytegen Executive Team (2)

Name Title Board
Seat
Contact
Info
Blake Hill Co-Founder & Chief Scientific Officer
George Ugras Ph.D Co-Founder, President & Board Member

Cytegen Board Members (2)

Name Representing Role Since Contact
Info
George Ugras Ph.D Self Co-Founder, President & Board Member 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »